RM Global Partners bags $30 mln for Israeli biopharma fund
RM Global Partners has raised $30 million in the first close of its Israel-based biopharma fund. The RMGP Biopharma Fund will invest in the FutuRx portfolio, an Israel-based incubator founded by Johnson & Johnson, Takeda Ventures and OrbiMed.
19 May 2017•3 mins read
